Trump Fast-Tracks Psychedelics After Joe Rogan Texts Him About a Schedule I Drug
The first hit’s free…
Well it appears federal drug policy is now being conducted via iMessage. Donny Schrooms (read: Trump) signed an executive order on Saturday to fast-track psychedelic drugs, including ibogaine… a Schedule I substance in the same legal category as heroin. Joe Rogan texted him about it and Trump responded, word for word (according to Rogan): "Sounds great. Do you want FDA approval? Let's do it." Side note: Find you a friend like Trump.
In short, Rogan was in the Oval Office for the signing alongside Marcus Luttrell, the former Navy SEAL behind Lone Survivor, and Health Secretary RFK Jr. The order directs the FDA to issue national priority vouchers for three psychedelics, pave the way for the first-ever U.S. human trials of ibogaine, and drop $50 million in federal research funding. Commissioner Makary says the vouchers will let certain drugs get approved in weeks instead of months "if they are in line with our national priorities."
For those just catching up here, ibogaine comes from a West African shrub, has been used in Bwiti religious ceremonies in Gabon for years, and is currently banned under the feds' most restrictive drug classification. Veterans have been pushing it for years for PTSD and opioid addiction. The catch: it's also linked to 30+ deaths from cardiac complications, and the NIH funded research in the '90s before noping out over "cardiovascular toxicity” which just a smart word for putting the attack in heart attack.
However, veterans keep going anyway… to Mexico. Clinics in Cancún have been treating Americans at $15K to $20K a pop. Former Texas Gov. Rick Perry, the man who couldn't remember the third government agency he wanted to eliminate on live TV, co-founded Americans for Ibogaine and helped secure $50 million in Texas state funding for clinical trials. And yet, he also appeared on Rogan’s podcast to make the case… twice.
As for the actual science, it’s not exactly airtight. The only recent U.S.-linked study enrolled 30 veterans in Mexico, had no placebo group, and combined ibogaine with magnesium to reduce the cardiac arrest risk. Johns Hopkins' Frederick Barrett called it "incredibly difficult to study." Clinic owners say the impact won't be immediate either… no insurance coverage, still unapproved. But the policy pipeline in 2026 doesn't give a sh*t about sample sizes.
Case in point: The process goes podcast guest → Rogan → text message to Trump → executive order → FDA fast-track. Curtis Wright walked so Psychedlics could run. Which means fluoride guy is the running point on psychedelic drug policy, and the podcaster who interviews MMA fighters between elk hunts is making pharmaceutical recommendations to the leader of the free world via iMessage. To which I say, this is peak 2026.
In the meantime, how do I get my hands on ibogaine? Asking for a friend. Until next time…

At the time of publishing, Stocks.News does not hold positions in companies mentioned in the article.